CoChat

The DOI matches its Crossref record; 111 of the 113 references it cites were found in a registry or an index.

Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery

Open access
Fu, Jingyu, Qiu, Hailong, Tan, Cherie S. · 2023 · Pharmaceutics

Abstract

Drug discovery is an expensive, long, and complex process, usually with a high degree of uncertainty. In order to improve the efficiency of drug development, effective methods are demanded to screen lead molecules and eliminate toxic compounds in the preclinical pipeline. Drug metabolism is crucial in determining the efficacy and potential side effects, mainly in the liver. Recently, the liver-on-a-chip (LoC) platform based on microfluidic technology has attracted widespread attention. LoC systems can be applied to predict drug metabolism and hepatotoxicity or to investigate PK/PD (pharmacokinetics/pharmacodynamics) performance when combined with other artificial organ-on-chips. This review discusses the liver physiological microenvironment simulated by LoC, especially the cell compositions and roles. We summarize the current methods of constructing LoC and the pharmacological and toxicological application of LoC in preclinical research. In conclusion, we also discussed the limitations of LoC in drug discovery and proposed a direction for improvement, which may provide an agenda for further research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics15041300

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) Cell distribution structure in a liver lobule. Double blood supply of hepatic arteriole and portal vein enters the liver’s portal triad region and the central vein. (B) Three-dimensional liver tissue diagram in LoC. The fluid flows through the pores on the scaffold, providing the biochemical environment and mechanical stimulation. (C) Microstructure of liver. The liver lobule is hexagonal, with a 1 mm diameter and a 2 mm thickness, functionally divided into three regions. (D) Example of zonal heterogeneity of hepatotoxicity. The yellow arrow shows the flow direction. (A,B) reproduced with permission of [34], Copyright © 2017. Published by Elsevier. (C,D) reproduced with permission of [29], Copyright © 2019. Published by MDPI.
Figure 1 (A) Cell distribution structure in a liver lobule. Double blood supply of hepatic arteriole and portal vein enters the liver’s portal triad region and the central vein. (B) Three-dimensional liver tissue diagram in LoC. The fluid flows through the pores on the scaffold, providing the biochemical environment and mechanical stimulation. (C) Microstructure of liver. The liver lobule is hexagonal, with a 1 mm diameter and a 2 mm thickness, functionally divided into three regions. (D) Example of zonal heterogeneity of hepatotoxicity. The yellow arrow shows the flow direction. (A,B) reproduced with permission of [34], Copyright © 2017. Published by Elsevier. (C,D) reproduced with permission of [29], Copyright © 2019. Published by MDPI.CC BY · PubMed Central
Figure 2 Different microfluidic models are used to construct liver-on-a-chip. (A) A 24-well PDMS mold with through holes at the bottom. Hepatocytes (labeled green) selectively adhered to the collagen structure, clustered together, and then surrounded by mouse 3T3-J2 fibroblasts (labeled orange). (B) Microfluidic endothelial-like barrier. The barrier consists of parallel channels connecting the cell culture zone with the external flow channel. (C) Simulation of liver lobules in Christmas tree structure, with gradient generator. (D) Spheroid culture. Cultured spheroids in an ultra-low-attachment plate, transferred them to a 96-well plate or liver chip and compared their performance. (A) reproduced with permission of [11], Copyright © 2008. Published by Nature Publishing Group. (B) reproduced with permission of [78], Copyright © 2007. Published by Wiley Periodicals, Inc. (C) reproduced with permission of [79], Copyright © 2018. Published by Nature Publishing Group. (D) reproduced with permission of [80], Copyright © 2022 Published by Elsevier.
Figure 2 Different microfluidic models are used to construct liver-on-a-chip. (A) A 24-well PDMS mold with through holes at the bottom. Hepatocytes (labeled green) selectively adhered to the collagen structure, clustered together, and then surrounded by mouse 3T3-J2 fibroblasts (labeled orange). (B) Microfluidic endothelial-like barrier. The barrier consists of parallel channels connecting the cell culture zone with the external flow channel. (C) Simulation of liver lobules in Christmas tree structure, with gradient generator. (D) Spheroid culture. Cultured spheroids in an ultra-low-attachment plate, transferred them to a 96-well plate or liver chip and compared their performance. (A) reproduced with permission of [11], Copyright © 2008. Published by Nature Publishing Group. (B) reproduced with permission of [78], Copyright © 2007. Published by Wiley Periodicals, Inc. (C) reproduced with permission of [79], Copyright © 2018. Published by Nature Publishing Group. (D) reproduced with permission of [80], Copyright © 2022 Published by Elsevier.CC BY · PubMed Central
Figure 3 Example of 3D perfusion platforms. (A) Twelve fluid-isolated bioreactors with connected cell culture plate (yellow) and pneumatic plate (gray). (B) Cross section diagram of the bioreactor, the membrane separates the upper cell culture plate from the lower pneumatic plate, and the micropump provides power for medium circulation in the channel. (C) OrganoPlate LiverTox model. The iHeps differentiated in 2D culture are harvested and seeded in OrganoPlate 2-lane through a liquid processor. Perfusion and organ channels were separated by phase guidance (PhG). (A,B) reproduced with permission of [16], Copyright © 2016. Published by The American Society for Pharmacology and Experimental Therapeutics. (C) reproduced with permission of [20], Copyright © 2021. Published by Elsevier.
Figure 3 Example of 3D perfusion platforms. (A) Twelve fluid-isolated bioreactors with connected cell culture plate (yellow) and pneumatic plate (gray). (B) Cross section diagram of the bioreactor, the membrane separates the upper cell culture plate from the lower pneumatic plate, and the micropump provides power for medium circulation in the channel. (C) OrganoPlate LiverTox model. The iHeps differentiated in 2D culture are harvested and seeded in OrganoPlate 2-lane through a liquid processor. Perfusion and organ channels were separated by phase guidance (PhG). (A,B) reproduced with permission of [16], Copyright © 2016. Published by The American Society for Pharmacology and Experimental Therapeutics. (C) reproduced with permission of [20], Copyright © 2021. Published by Elsevier.CC BY · PubMed Central
Figure 4 Example of multi-organ chips platforms. (A) Multi-organ chips based on liver, intestinal, vascular, and kidney chips. Caco-2, HUVEC, HepG2, and HK-2 occupy one floor from top to bottom (B) Taking a two-layer chip assembly as an example, the system was built in the order of inoculating cells to a porous membrane, providing a cell culture medium and assembling chips. The peristaltic pump provides power for fluid. (C) The liver and lung cancer parts on chips are connected through a microchannel. Channel is also equipped with a stirrer-based micropump to provide power. The value in the arrow is the flow ratio. (D) Concept diagram of PK model based on the multi-organ chip. (A,B), reproduced with permission of [23], Copyright © 2020. Published by Elsevier. (C,D) reproduced with permission of [91], Copyright © 2020. Published by AIP Publishing.
Figure 4 Example of multi-organ chips platforms. (A) Multi-organ chips based on liver, intestinal, vascular, and kidney chips. Caco-2, HUVEC, HepG2, and HK-2 occupy one floor from top to bottom (B) Taking a two-layer chip assembly as an example, the system was built in the order of inoculating cells to a porous membrane, providing a cell culture medium and assembling chips. The peristaltic pump provides power for fluid. (C) The liver and lung cancer parts on chips are connected through a microchannel. Channel is also equipped with a stirrer-based micropump to provide power. The value in the arrow is the flow ratio. (D) Concept diagram of PK model based on the multi-organ chip. (A,B), reproduced with permission of [23], Copyright © 2020. Published by Elsevier. (C,D) reproduced with permission of [91], Copyright © 2020. Published by AIP Publishing.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 113 references

Cited by

See all 47

Metadata

Authors
Fu, J., Qiu, H., & Tan, C. S.
Affiliations
  • Tianjin University (CN)
  • Tianjin University of Technology (CN)
Corresponding author
  • Qiu, Hailong
  • Tan, Cherie S.
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2023-04-21
Volume
15
Issue
4
Pages
1300
ISSN
1999-4923 (ISSN-L)
OpenAlex
W4366773405
Cited by
42
References
113
Citations by year
2026: 18 · 2025: 20 · 2024: 2 · 2023: 2
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (22274110, 22250610197, 51872198, 21904094, 2021-JCJQ-JJ-0639, GG20210301)
  • National Defense Science and Technology 173 Program (22274110, 22250610197, 51872198, 21904094, 2021-JCJQ-JJ-0639, GG20210301)
  • National Key Research and Development Program of China (22274110, 22250610197, 51872198, 21904094, 2021-JCJQ-JJ-0639, GG20210301)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
liver-on-a-chip, organ-on-a-chip, preclinical drug discovery, drug metabolism, hepatotoxicity prediction, pharmacokinetics/pharmacodynamics, liver microenvironment, drug screening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery. https://app.cochat.ai/papers/10.3390/pharmaceutics15041300
The paper
Fu, J., Qiu, H., & Tan, C. S. (2023). Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15041300

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.